Consequently, this intervention mitigated weight loss, lowered fasting blood glucose levels and hemoglobin A1c, enhanced glucose tolerance, and increased fasting serum insulin in T2DM rats (Zhong et al., 2022). The gene discussed is INS; the disease is type 2 diabetes mellitus.